Desloratadine

地氯雷他定

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameDesloratadine
Drug Alias Name右氯雷他定DescarboethoxyloratadineAllex地洛他定脱羧氯雷他定 +[18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsFastingHypersensitivityChronic Urticaria +[15
Global Approved IndicationsChronic UrticariaUrticariaPruritus +[8
Approved Indications in ChinaUrticariaRhinitis, Allergic, Seasonal
Original Approved Country/TerritoryEU
Original Approved Date2001/01/15
Country/TerritoryUnited StatesGermanyEgypt +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active IndicationsChronic UrticariaUrticariaPruritus +[11
Inactive IndicationsFastingHypersensitivityDermatitis, Atopic +[4

Other Information

ATC CodeR06AX27